VANCOUVER, B.C. - QLT Inc. (TSX:QLT) said revenues from sales of its flagship Visudyne treatment for age-related blindness fell nearly 20 per cent in the third quarter compared to last year, but that its share of profit from the drug was up.
Who Voted for this Story
LiftSP Anti-Wrinkle Cream
Lose Weight with Acai
Comments